However, breast cancer is a highly heterogeneous disease, being classified as luminal (oestrogen receptor (ER)/ progesterone receptor (PR)-positive, HER2-negative), HER2-enriched (HER2-positive) or triple-negative (negative to ER, PR and HER2) [3]. Here, ERBB2 is linked to breast carcinoma.